Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe(3)O(4) nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drug

Camptothecin (CPT) is an anti-cancer drug that effectively treats various cancers, including colon cancer. However, poor solubility and other drawbacks have restricted its chemotherapeutic potential. To overcome these restrictions, CPT was encapsulated in CEF (cyclodextrin-EDTA-FE(3)O(4)), a composi...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnan, Poorani, Rajan, Mariappan, Kumari, Sharmilah, Sakinah, S., Priya, Sivan Padma, Amira, Fatin, Danjuma, Lawal, Pooi Ling, Mok, Fakurazi, Sharida, Arulselvan, Palanisamy, Higuchi, Akon, Arumugam, Ramitha, Alarfaj, Abdullah A., Munusamy, Murugan A., Hamat, Rukman Awang, Benelli, Giovanni, Murugan, Kadarkarai, Kumar, S. Suresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591276/
https://www.ncbi.nlm.nih.gov/pubmed/28887536
http://dx.doi.org/10.1038/s41598-017-09140-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591276/
https://www.ncbi.nlm.nih.gov/pubmed/28887536
http://dx.doi.org/10.1038/s41598-017-09140-1

Ejemplares similares